Forecast & Rating7 analysts currently cover Amicus Therap, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $14.50, about 0.1% upside from the current price of $14.49. Historically, about 8.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Amicus Therap's outlook. Data as of Apr 27, 2026; for reference only and not investment advice.
Apr 2, 2026Price forecast
$14.500.07%
Forecast & RatingHold
7analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateApr 19, 2026
Forecast met11.6%
Stock price$14.49
Avg. target$14.5
High target$15
Low target$15
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.